Contrast-Enhanced Ultrasound Evaluates Pathological Response Grades After Neoadjuvant Therapy in Colorectal Liver Metastases
Academic Radiology · 2026-09
DOI: 10.1016/j.acra.2026.09.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Radiology, 2026-09. Verfasst von Hong Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospi…. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Peking University.
Abstract (Originalsprache)
RATIONALE AND OBJECTIVES: Precise assessment of pathological response grades after neoadjuvant therapy in colorectal liver metastases (CRLM) is essential for facilitating individualized therapeutic decision-making. OBJECTIVES: To establish a one-step contrast-enhanced ultrasound (CEUS) classification system to evaluate five grades of pathological response after neoadjuvant therapy in CRLM. MATERIALS AND METHODS: This study was conducted with CRLM who underwent preoperative CEUS following neoadjuvant therapy from January 2023 to December 2024. Pathological response was graded according to tumor regression grade (TRG) scheme. Accordingly, CEUS five-grade patterns were established based on perfusion characteristics of wash-in at arterial-phase and washout at portal vein and late phase, including: ①Non-enhanced, ②Slow In/Slow Out, ③Slow In/Fast Out, ④Fast In/Slow Out, ⑤Fast In/Fast Out. Inter-reader agreement was assessed using Cohen's kappa. Diagnostic performance of CEUS and concurrent contrast-enhanced MRI (CEMRI) were evaluated using McNemar's test and DeLong test (TRG 1-3: favorable pathological response; TRG 4-5: poor pathological response). RESULTS: A total of 217 patients (mean age 58±10 years; 148 male) were enrolled into this study. CEUS five-grade patterns were strongly correlated with five TRGs (Spearman r=0.812, P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, No. 52 Fucheng Road, Haidian District, Beijing 1001…
- Department of Radiology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, No. 52 Fucheng Road, Haidian District, Beijing 10014…
- Department of Pathology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, No. 52 Fucheng Road, Haidian District, Beijing 10014…
Förderung
- National Natural Science Foundation of China
- Peking University
Zitieren
APA
Wang, H., Liu, L., Cao, K., Li, Y., Wang, S., Zhang, Z. Y., Wu, W., Yan, K., Sun, Y., & Yang, W. (2026). Contrast-Enhanced Ultrasound Evaluates Pathological Response Grades After Neoadjuvant Therapy in Colorectal Liver Metastases. Academic Radiology. https://doi.org/10.1016/j.acra.2026.09.015
Vancouver
Wang H, Liu L, Cao K, Li Y, Wang S, Zhang ZY, et al. Contrast-Enhanced Ultrasound Evaluates Pathological Response Grades After Neoadjuvant Therapy in Colorectal Liver Metastases. Academic Radiology. 2026. doi:10.1016/j.acra.2026.09.015
BibTeX
@article{Wang2026,
author = {Wang, Hong and Liu, Li and Cao, Kun and Li, Ying and Wang, Song and Zhang, Zhong-Yi and Wu, Wei and Yan, Kun and Sun, Yu and Yang, Wei},
title = {Contrast-Enhanced Ultrasound Evaluates Pathological Response Grades After Neoadjuvant Therapy in Colorectal Liver Metastases},
journal = {Academic Radiology},
year = {2026},
doi = {10.1016/j.acra.2026.09.015}
}
EUVIMED